Unknown

Dataset Information

0

MTOR: A possible therapeutic target against SARS-CoV-2 infection.

ABSTRACT:

SUBMITTER: Khan N 

PROVIDER: S-EPMC8225252 | biostudies-literature |

REPOSITORIES: biostudies-literature

Json Xml

Similar Datasets

Unknown Cannabinoid Receptor Type 2: A Possible Target in SARS-CoV-2 (CoV-19) Infection?
| S-EPMC7312493 | biostudies-literature
Unknown Potential and Possible Therapeutic Effects of Melatonin on SARS-CoV-2 Infection.
| S-EPMC8772978 | biostudies-literature
Unknown New perspective towards therapeutic regimen against SARS-CoV-2 infection.
| S-EPMC8152204 | biostudies-literature
Unknown Vitamin C promotes ACE2 degradation and protects against SARS-CoV-2 infection
| S-SCDT-10_15252-EMBR_202256374 | biostudies-other
Unknown Fluoxetine hydrochloride loaded lipid polymer hybrid nanoparticles showed possible efficiency against SARS-CoV-2 infection.
| S-EPMC8372442 | biostudies-literature
Unknown Control of complement-induced inflammatory responses to SARS-CoV-2 infection by anti-SARS-CoV-2 antibodies
| S-SCDT-10_1038-S44318-024-00061-0 | biostudies-other
Unknown Therapeutic approaches for SARS-CoV-2 infection.
| S-EPMC8096528 | biostudies-literature
Unknown Virtual screening of potential phyto-candidates as therapeutic leads against SARS-CoV-2 infection
| S-EPMC8110638 | biostudies-literature
Unknown Bioengineered angiotensin-converting-enzyme-2: a potential therapeutic option against SARS-CoV-2 infection
| S-EPMC8589099 | biostudies-literature
Unknown Janus kinase signaling as risk factor and therapeutic target for severe SARS-CoV-2 infection.
| S-EPMC8250126 | biostudies-literature